|
|
|
17-May-13
|
Fresh from returning to public ownership with a US$947
million offering, Quintiles has made a significant addition to its roster of
strategic alliances in the form of a five-year clinical development agreement
with Merck Serono.
In fact, the agreement involves a level of co-operation
beyond that usually seen in what is now a well...
|
|
|
|
|
10-May-13
|
The R&D numbers for the top 10 biotechs may only amount to a fraction of what you'll find in Big Pharma. But unlike the giants, which are trying to keep a lid on multibillion-dollar budgets, you'll find a much faster crowd when you turn your gaze to the biotechs.
All...
|
|
|
|
|
03-May-13
|
Parexel delivered another strong quarter of growth in revenue and operating profits, ahead of analysts’ estimates, for the three months ended 31 March 2013.
The company also bolstered its capabilities in the market-access space by acquiring Heron Group, a life sciences...
|
|
|
|
|
03-May-13
|
H.Lundbeck has introduced the first approved medication reducing alcohol consumption in alcohol dependent patients in Norway, Finland, Poland and the Baltic markets. Additional launches in other...
|
|
|
|
|
26-Apr-13
|
i-Pharm's new German office opened for business at Theresienhoehe 28, Munich, on Tuesday 2nd April 2013. This is an exciting development for the company and demonstrates our ongoing commitment to servicing the needs of our clients and candidates in the DACH region....
|
|
|
|
|
22-Apr-13
|
Johnson & Johnson has posted an 8.5% increase in sales for the first quarter,
helped by a strong showing at its pharmaceuticals division.
Group net income came in at $3.50 billion, down 10.6%...
|
|
|
|
|
19-Apr-13
|
Valeant Pharmaceuticals and Actavis are getting downright buddy-buddy.
Less than a week after partnering up on three skin products, the two companies have wrapped up a patent fight over two others. The settlement sets launch dates for both copycat versions, and gives Valeant a share in the proceeds.
The new patent deal involves...
|
|
|
|
|
12-Apr-13
|
The FDA has endorsed Pfizer's ($PFE) high hopes for the breast cancer drug palbociclib (or PD-0332991), handing out its coveted...
|
|
|
|
|
28-Feb-13
|
i-Pharm's DACH region team will be relocating to a brand new office in Munich, Germany, opening on 2nd April 2013. i-Pharm has been operational in the German and Swiss markets since 2008 and the opening of the new DACH region HQ is a further commitment to expanding the business in the region. Further details...
|
|
|
|
|
21-Jan-13
|
US regulators have approved, for the first time, a patch to treat migraine, claimed by its makers to be a "game-changing" new treatment option for sufferers - particularly for those also affected by related nausea.
The US Food and Drug Administration has issued a green light for NuPathe's Zecuity to relieve...
|
|
|
|
|
26-Oct-12
|
Takeda is paying $60 million upfront to acquire the USA's LigoCyte Pharmaceuticals and expand its vaccines business.
The Japan-based major will pay more depending on the progress of certain projects being developed by LigoCyte, a privately-held company headquartered in Bozeman, Montana. Its lead product, a vaccine to prevent norovirus gastroenteritis, is in...
|
|
|
|
|
19-Oct-12
|
Anyone who follows pharma knows that FDA has called manufacturers on the carpet quite often over the past few years. One by one, some of the biggest names in the industry have had to ratchet back or suspend production to fix some scary-sounding manufacturing violations.
The New York Times catalogs some of...
|
|
|
|
|
21-Sep-12
|
Penny-pinching governments have put pharma's head in a vise, Bayer CEO Marijn Dekkers says. Joining a chorus of pharma executives, Dekkers warned that continuing to squeeze drug prices will crush innovation and drain the lifeblood from the R&D-based business model.
"The profits that we make on the current drugs really...
|
|
|
|
|
24-Aug-12
|
Almost 30 years after discovery of a link between alcohol consumption and certain forms of cancer, scientists are reporting the first evidence from research on people explaining how the popular beverage may be carcinogenic. The results, which have special implications for hundreds of millions of people of Asian descent, were reported...
|
|
|
|
|
16-Aug-12
|
The pharmaceutical company Boehringer Ingelheim has grown again in the current financial year. In the first half of 2012, currency-adjusted sales increased by 6.8% compared with the previous year to €7.1 billion. The increased sales were driven by the established respiratory tract medication SPIRIVA® and COMBIVENT®, both of which experienced double-digit...
|
|
|
|
|
12-Jul-12
|
As part of i-Pharm's continued growth in 2012, July saw the arrival of 2 new consultants, Will Hitchcock and Aoife Cronin. Will and Aoife will be bolstering our Pharmaceutical Manufacturing and Health Economics teams respectively - both sectors that have grown exponentially for i-Pharm in the last 12 months. ...
|
|
|
|
|
22-Jun-12
|
i-Pharm are delighted to announce that we will be sponsoring the Civil Service Football Club again for season 2012/2013.
The Civil Service Football Club was a founder member of the Football Association, establihsed in 1863! The club runs 8 teams playing in the UK Southern Amateur League (SAL) as well as a...
|
|
|
|
|
25-May-12
|
i-Pharm has continued to grow it's team covering the Pharmaceutical market in the DACH region (Germany, Austria, Switzerland). We now have a team of 5 native German speakers covering the region and plan to further grow this team in 2012! New office in Munich scheduled to open in H1 2013!...
|
|
|
|
|
16-Feb-12
|
On the evening of the 16th February, the great and the good of the UK Pharmaceutical industry gathered in the Riverbank Plaza Hotel in London for the annual Pharmatimes Clinical Research awards.
We are delighted to announce that our very own Stephen McAnaney was nominated in the Clinical Recruiter category. Unique...
|
|
